4556 — Kainos Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareAdventurousMicro CapContrarian
- ¥4bn
- ¥2bn
- ¥5bn
- 88
- 83
- 22
- 75
Annual cashflow statement for Kainos Laboratories, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 590 | 599 | 613 | 767 | 845 |
| Depreciation | |||||
| Non-Cash Items | 10.7 | 18.9 | 47.1 | 12.4 | 10.9 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -309 | -75.5 | -211 | -325 | -453 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 425 | 678 | 591 | 604 | 545 |
| Capital Expenditures | -127 | -55.1 | -73.2 | -141 | -7.7 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 107 | 2.91 | -44 | -0.017 | -2.63 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -19.9 | -52.2 | -117 | -141 | -10.3 |
| Financing Cash Flow Items | 15.7 | -0.001 | -0.001 | -0.001 | -0.001 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -648 | 386 | -195 | -31.3 | -191 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -244 | 1,011 | 280 | 433 | 343 |